Stereochemical composition of clenbuterol residues in edible tissues of swine

Journal of Agricultural and Food Chemistry

Volumn 48, Issue 12, 2000, Pages 6036-6043

  Smith, D J ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Chiral; Clenbuterol; Hogs; Residues; Stereoisomer

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CLENBUTEROL; DRUG RESIDUE; OXAZOLINE DERIVATIVE; PHOSGENE; TISSUE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CHIRALITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; ENANTIOMER; MASS SPECTROMETRY; NONHUMAN; STEREOCHEMISTRY; SWINE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CLENBUTEROL; DRUG RESIDUES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; MEAT; STEREOISOMERISM; SWINE; TIME FACTORS;

EID: 0034527183     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf001054v     Document Type: Article

References (58)

1. Abou-Basha, L. I.; Aboul-Enein, H. Y. Direct enantioselective separation of clenbutcrol by chiral HPLC in biological fluids. Biomed. Chromatogr. 1996, 10, 69-72.
2. Aboul-Enein, H. Y.; Serignese, V. Quantitative determination of clenbuterol enantiomers in human plasma by high-performance liquid chromatography using the macrocyclic antibiotic chiral stationary phase teicoplanin. Biomed. Chromatogr. 1999, 13, 520-524.
3. Abukhalaf, I. K.; von Deutsch, D. A.; Parks, B. A.; Wineski, L.; Paulsen, D.; Aboul-Enein, H. Y.; Potter, D. E.. Comparative analytical, quantitation of clenbuterol in biological matricies using GC-MS and EIA. Biomed. Chromatogr. 2000, 14, 99-105.
4. Altria, K. D.; Harden, R. C.; Hart, M.; Hevizi, J.; Hailey, P. A. Inter-company cross-validation exercise on capillary electrophoresis. J. Chromatogr. 1993, 641, 147-153.
5. Anderson, D. B.; Veenhuizen, E. L.; Jones, D. J.; Schroeder, A. L.; Hancock, D. L. The use of phenethanolamines to reduce fat and increase carcass leanness in meat animals. In Fat and Cholesterol Reduced Foods: Technologies and Strategies; Bray, G., Ed.; Portfolio Publishing: Wood, TX, 1990.
6. Anonymous. Chinese farmers charged with giving pigs illegal growth drug. World Food Chem. News 1998, 5, 13.
7. Boenisch, B.; Quirke, J. F. Safety assessment of β-agonists. In In Vitro Toxicological Studies and Real Time Analysis of Residues in Food, FLAIR-Concerted Action 8; Proceedings of the Workshop held in Ghent, May 22-24, 1992, and Thessaloniki, Oct 30-31, 1992; Kuiper, H. A., Hoogenboom, L. A. P., Eds.; RIKILT-DLO: Wageningen, The Netherlands, 1992.
8. Boulton, D. W.; Fawcett, J. P. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br. J. Clin. Pharmacol. 1996, 41, 35-40.
9. Boulton, D. W.; Fawcett, J. P. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans. Clin. Pharmacol. Ther. 1997, 62, 138-144.
10. Brambilla, G.; Loizzo A.; Fontana, L.; Strozzi, M.; Guarino, A.; Soprano, V. Food poisoning following consumption of clenbuterol-treated veal in Italy. JAMA-J. Am. Med. Assoc. 1997, 278, 635.
11. Brambilla, G.; Cenci, T.; Franconi, F.; Galarini, R.; Macri, A.; Rondoni, F.; Strozzi, M.; Loizzo, A. Clinical and pharmaco-logical profile in a clenbuterol epidemic poisoning of contaminated beef meet in Italy. Toxicol. Lett. 2000, 114, 47-53.
12. Chan, T. Y. K. Health hazards due to clenbuterol residues in food. Clin. Toxicol. 1998, 37, 517-519.
13. Dalidowicz, J. E.; Thomson, T. D.; Babbitt, G. E. Ractopamine hydrochloride, a phenethanolamine repartitioning agent: Metabolism and residues. In Xenobiotics and Food-Producing Animals; Hutson, D. H., Hawkins, D. R., Paulson, G. D., Struble, C. B., Eds.; American Chemical Society: Washington, DC, 1992.
14. Dhand, R.; Goode, M.; Ralston, R.; Fink, J. B.; Fahey, P. J.; Tobin, M. J. Preferential pulmonary retention of (S)-al-buterol after inhalation of racemic albuterol. Am. J. Respir. Crit. Care Med. 1999, 160, 1136-1141.
15. Eaton, E. A.; Walle, U. K.; Wilson, H. M.; Aberg, G.; Walle, T. Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br. J. Clin. Pharmacol. 1996, 41, 201-206.
16. Elliott, C. T.; Shortt, H. D.; Kennedy, D. G.; McCaughey, W. J. Monitoring for clenbuterol abuse in N. Ireland 1989-1994. Vet. Q. 1996, 18, 41-44.
17. Gausepohl, C.; Blaschke, G. Stereoselective determination of clenbuterol in human urine by capillary electrophoresis. J. Chromatogr. B 1998, 713, 443-446.
18. Guyer, C. G.; Miller, M. A. Human Food Safety Evaluation of Repartitioning Agents. In Low-Fat Meats: Design Strategies and Human Implications; Hafs, H. D., Zimbelman, R. G., Eds.; Academic Press: San Diego, CA, 1994.
19. Handley, D. The asthma-like pharmacology and toxicology of (S)-isomers of β-agonists. J. Allergy Clin. Immunol. 1999, 104, S69-S76.
20. Heitzman, R. J. Clenbuterol. In Residues of Some Veterinary Drugs in Animals and Foods; FAO Food and Nutrition Paper 41/9; Food and Agriculture Organization of the United Nations: Rome, Italy, 1997.
21. Kuiper, H. A.; Noordam, M. Y.; van Dooren-Flipsen, M. M. H.; Schilt, R.; Roos, A. H. Illegal use of β-adrenergic agonists: European Community. J. Anim. Sci. 1998, 76, 195-207.
22. 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in health volunteers. Thorax 1997, 52, 849-852.
23. Malucelli, A.; Ellendorff, F.; Meyer, H. H. D. Tissue distribution and residues of clenbuterol, salbutamol, and terbutaline in tissues of treated broiler chicks. J. Anim. Sci. 1994, 72, 1555-1560.
24. Martínez-Navarro, J. F. Food poisoning related to consumption of illicit β-agonist in liver. Lancet 1990, 336, 1311.
25. Melville, R. Beta agonist debate in Thailand. Pig Int. 2000, 30, 23-24.
26. Meyer, H. H. D.; Rinke, L. M. The pharmacokinetics and residues of clenbuterol in veal calves. J. Anim. Sci. 1991, 65, 4538-4544.
27. Mitchell, G. A.; Dunnavan, G. Illegal use of β-agonists in the United States. J. Anim. Sci. 1998, 76, 208-211.
28. Morgan, D. J. Clinical Pharmacokinetics of β-agonists. Clin. Pharmacokin. 1990, 18, 270-294.
29. Muirhead, S. CVM approves leanness enhancer for use in food production animals. Feedstuffs 2000, 72, 1.
30. Nazzal, C. A. The clinical pharmacology of clenbuterol. South-west. Vet. 1985, 36, 121-125.
31. Page, C. P.; Morley, J. Contrasting properties of albuterol stereoisomers. J. Allergy Clin. Immunol. 1999, 104, S31-S41.
32. Prior, C.; Leonard, M. B.; McCullough, J. R. Effects of the enantiomers of R,S-salbutamol on incompletely fused tetanic contractions of slow- and fast-twitch skeletal muscles of the guinea-pig. Br. J. Pharmacol. 1998, 123, 558-564.
33. Pulce, C.; Lamaison, D.; Keck, G.; Bostvironnois, C.; Nicolas, J.; Descotes, J. Collective human food poisonings by clenbuterol residues in veal liver. Vet. Hum. Toxicol. 1991, 33, 480-481.
34. Reed, C. E. Adrenergic bronchodilators: Pharmacology and toxicology. J. Allergy Clin. Immunol. 1985, 76, 335-341.
35. Ricke, E. A.; Smith, D. J.; Feil, V. J.; Larsen, G. L.; Caton, J. S. Effects of ractopamine HCl stereoisomers on growth, nitrogen retention, and carcass composition in rats. J. Anim. Sci. 1999, 77, 701-707.
36. Ruffolo, R. R. Chirality in α- and β-adrenoceptor agonists and antagonists. Tetrahedron 1991, 47, 9953-9980.
37. Salleras, L.; Domínguez, A.; Mata, E.; Taberner, J. L.; Moro, I.; Salvá, P. Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain. Public Health Rep. 1995, 110, 338-342.
38. Schmid, J.; Prox, A.; Zimmer, A.; Keck, J.; Kaschke, S. Biotransformation of clenbuterol. Fresenius' J. Anal. Chem. 1990, 337, 121 (Abstr.).
39. 12 mouse and turkey cells to the β-adrenergic agonist ractopamine. J. Anim. Sci. 2000, 78, 699-708.
40. Smith, D. J. The pharmacokinetics, metabolism, and tissue residues of β-adrenergic agonists in livestock. J. Anim. Sci. 1998a, 76, 173-194.
41. 14C] clenbuterol HCl and three preslaughter withdrawal periods. J. Anim. Sci. 1998b, 76, 3043-3053.
42. 14C]clenbuterol for seven days and pre-slaughter withdrawal periods of 0, 3, or 7 days. J. Anim. Sci. 2000, 78, 2903-2912.
43. Smith, D. J.; Buchenau, M. Analysis of commercial premixes and feeds for the presence of β-adrenergic agonists. Presented at the American Chemical Society National Meeting, Anaheim, CA, March 21-25, 1999; Picogram 56:Abstract 62.
44. 14C]clenbuterol HCl in Holstein calves. J. Anim. Sci. 1997, 75, 454-461.
45. Spangler, D. L. Review of side effects associated with beta agonists. Ann. Allergy 1989, 62, 59-62.
46. Sporano, V.; Grasso, L.; Esposito, M.; Oliviero, G.; Brambilla, G.; Loizzo, A. Clenbuterol residues in non-liver containing meat as a cause of collective food poisoning. Vet. Hum. Toxicol. 1998, 40, 141-143.
47. U.S. Pharmacopeia. Entry for clenbuterol. USP Dictionary of USAN and International Drug Names; U.S. Pharmacopeia: Rockville, MD, 1998.
48. Waldeck, B.; Widmark, E. Steric aspects of agonism and antagonism at β-adrenoreceptors: Experiments with the enantiomers of clenbuterol. Acta Pharmacol. Toxicol. 1985, 56, 221-227.
49. Walle, U. K.; Pescola, G. R.; Walle, T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br. J. Clin. Pharmacol. 1993, 35, 413-418.
50. Weber, N. E. Use of xenobiotics in food-producing animals in the United States. In Xenobiotics and Food-Producing Animals; Hutson, D. H., Hawkins, D. R., Paulson, G. D., Struble, C. B., Eds.; American Chemical Society: Washington, DC, 1992.
51. Wilson, R. T.; Groneck, J. M.; Holland, K. P.; Henry, A. C. Determination of clenbuterol in cattle, sheep, and swine tissues by electron ionization gas chromatography/mass spectrometry. J. AOAC Int. 1994, 77, 917-924.
52. Woodward, K. N: Veterinary medicines: Regulation in Europe and the importance of pharmacokinetic studies. In Xenobiotics and Food-Producing Animals; Hutson, D. H., Hawkins, D. R., Paulson, G. D., Struble, C. B., Eds.; American Chemical Society: Washington, DC, 1992.
53. Yamaguchi H.; McCullough, J. R. S-Albuterol exacerbates calcium responses to carbachol in airway smooth muscle cells. Clin. Rev. Allergy Immunol. 1996, 14, 47-55.
54. Zalko, D.; Debrauwer, L.; Bories, G.; Tulliez, J. Evidence for a new and major metabolic pathway of clenbuterol involving in vivo formation of an N-hydroxylamine. Chem. Res. Toxicol. 1997, 10, 197-204.
55. Zalko, D.; Debrauwer, L.; Bories, G.; Tulliez, J. Metabolism of clenbuterol in rats. Drug. Metab. Dispos. 1998, 26, 891-899.
56. Zhang, J.; Grieve, D. G. Effects of β-agonists, L-644-969, on adipose depots in growing female rats. Can. J. Anim. Sci. 1995, 75, 79-83.
57. Zimmer, V. A. Pharmakokinetik und metabolitenmuster yon clenbuterol beim kaninchen un beim hund. Arzneim.-Forsch. (Drug Res.) 1976a, 26, 1442-1445.
58. Zimmer, V. A. Enmalapplikation, mehrfachapplication und metabolitenmuster von clenbuterol beim menschen. Arzneim.-Forsch. (Drug Res.) 1976b, 26, 1446-1450.